General Information of This Antigen
Antigen ID
TAR0XTCGM
Antigen Name
B-cell receptor CD22 (CD22)
Gene Name
CD22
Gene ID
933
Synonym
B-lymphocyte cell adhesion molecule;Sialic acid-binding Ig-like lectin 2;T-cell surface antigen Leu-14;CD_antigen=CD22
Sequence
MHLLGPWLLLLVLEYLAFSDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFH
NPEYNKNTSKFDGTRLYESTKDGKVPSEQKRVQFLGDKNKNCTLSIHPVHLNDSGQLGLR
MESKTEKWMERIHLNVSERPFPPHIQLPPEIQESQEVTLTCLLNFSCYGYPIQLQWLLEG
VPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFLSNDTVQLNVKH
TPKLEIKVTPSDAIVREGDSVTMTCEVSSSNPEYTTVSWLKDGTSLKKQNTFTLNLREVT
KDQSGKYCCQVSNDVGPGRSEEVFLQVQYAPEPSTVQILHSPAVEGSQVEFLCMSLANPL
PTNYTWYHNGKEMQGRTEEKVHIPKILPWHAGTYSCVAENILGTGQRGPGAELDVQYPPK
KVTTVIQNPMPIREGDTVTLSCNYNSSNPSVTRYEWKPHGAWEEPSLGVLKIQNVGWDNT
TIACAACNSWCSWASPVALNVQYAPRDVRVRKIKPLSEIHSGNSVSLQCDFSSSHPKEVQ
FFWEKNGRLLGKESQLNFDSISPEDAGSYSCWVNNSIGQTASKAWTLEVLYAPRRLRVSM
SPGDQVMEGKSATLTCESDANPPVSHYTWFDWNNQSLPYHSQKLRLEPVKVQHSGAYWCQ
GTNSVGKGRSPLSTLTVYYSPETIGRRVAVGLGSCLAILILAICGLKLQRRWKRTQSQQG
LQENSSGQSFFVRNKKVRRAPLSEGPHSLGCYNPMMEDGISYTTLRFPEMNIPRTGDAES
SEMQRPPPDCDDTVTYSALHKRQVGDYENVIPDFPEDEGIHYSELIQFGVGERPQAQENV
DYVILKH

    Click to Show/Hide
Family
LISCH7 family
Function
Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6- linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules.

    Click to Show/Hide
Uniprot Entry
CD22_HUMAN
HGNC ID
HGNC:1643
KEGG ID
hsa:933
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Anti-CD22 10F4 Thiomab (LC:K149C)
ADC Info ADC Name Payload Target Linker Ref
Anti-CD22-SN36248
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2
[1]
Anti-CD22 Anti-ody (LC-K149C)
ADC Info ADC Name Payload Target Linker Ref
Anti-CD22-SPDB-DM4
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
[2]
Anti-CD22-K149C-MBT-DM4
Mertansine DM4
Microtubule (MT)
MBT
[2]
Anti-CD22-K149C-MPEO-DM1
Mertansine DM1
Microtubule (MT)
MPEO
[2]
Anti-CD22-K149C-DM1
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
[2]
Anti-CD22 mAb AbBJ
ADC Info ADC Name Payload Target Linker Ref
AbBJ-ConjA
AbBJ-ConjA payload
Undisclosed
AbBJ-ConjA linker
[3]
AbBJ-ConjB
AbBJ-ConjB payload
Undisclosed
AbBJ-ConjB linker
[3]
AbBJ-ConjC
AbBJ-ConjC payload
Undisclosed
AbBJ-ConjC linker
[3]
AbBJ-ConjD
AbBJ-ConjD payload
Undisclosed
AbBJ-ConjD linker
[3]
AbBJ-ConjE
AbBJ-ConjE payload
Undisclosed
AbBJ-ConjE linker
[3]
AbBJ-ConjF
AbBJ-ConjF payload
Undisclosed
AbBJ-ConjF linker
[3]
AbBJ-ConjG
AbBJ-ConjG payload
Undisclosed
AbBJ-ConjG linker
[3]
AbBJ-ConjH
AbBJ-ConjH payload
Undisclosed
AbBJ-ConjH linker
[3]
Anti-CD22 mAb AbCJX
ADC Info ADC Name Payload Target Linker Ref
AbCJX-ConjA
AbCJX-ConjA payload
Undisclosed
AbCJX-ConjA linker
[3]
AbCJX-ConjB
AbCJX-ConjB payload
Undisclosed
AbCJX-ConjB linker
[3]
AbCJX-ConjC
AbCJX-ConjC payload
Undisclosed
AbCJX-ConjC linker
[3]
AbCJX-ConjD
AbCJX-ConjD payload
Undisclosed
AbCJX-ConjD linker
[3]
AbCJX-ConjE
AbCJX-ConjE payload
Undisclosed
AbCJX-ConjE linker
[3]
AbCJX-ConjF
AbCJX-ConjF payload
Undisclosed
AbCJX-ConjF linker
[3]
AbCJX-ConjG
AbCJX-ConjG payload
Undisclosed
AbCJX-ConjG linker
[3]
AbCJX-ConjH
AbCJX-ConjH payload
Undisclosed
AbCJX-ConjH linker
[3]
Anti-CD22 mAb AbDJ
ADC Info ADC Name Payload Target Linker Ref
AbDJ-ConjA
AbDJ-ConjA payload
Undisclosed
AbDJ-ConjA linker
[3]
AbDJ-ConjB
AbDJ-ConjB payload
Undisclosed
AbDJ-ConjB linker
[3]
AbDJ-ConjC
AbDJ-ConjC payload
Undisclosed
AbDJ-ConjC linker
[3]
AbDJ-ConjD
AbDJ-ConjD payload
Undisclosed
AbDJ-ConjD linker
[3]
AbDJ-ConjE
AbDJ-ConjE payload
Undisclosed
AbDJ-ConjE linker
[3]
AbDJ-ConjF
AbDJ-ConjF payload
Undisclosed
AbDJ-ConjF linker
[3]
AbDJ-ConjG
AbDJ-ConjG payload
Undisclosed
AbDJ-ConjG linker
[3]
AbDJ-ConjH
AbDJ-ConjH payload
Undisclosed
AbDJ-ConjH linker
[3]
Anti-CD22 mAb AbHJ
ADC Info ADC Name Payload Target Linker Ref
AbHJ-ConjA
AbHJ-ConjA payload
Undisclosed
AbHJ-ConjA linker
[3]
AbHJ-ConjB
AbHJ-ConjB payload
Undisclosed
AbHJ-ConjB linker
[3]
AbHJ-ConjC
AbHJ-ConjC payload
Undisclosed
AbHJ-ConjC linker
[3]
AbHJ-ConjD
AbHJ-ConjD payload
Undisclosed
AbHJ-ConjD linker
[3]
AbHJ-ConjE
AbHJ-ConjE payload
Undisclosed
AbHJ-ConjE linker
[3]
AbHJ-ConjF
AbHJ-ConjF payload
Undisclosed
AbHJ-ConjF linker
[3]
AbHJ-ConjG
AbHJ-ConjG payload
Undisclosed
AbHJ-ConjG linker
[3]
AbHJ-ConjH
AbHJ-ConjH payload
Undisclosed
AbHJ-ConjH linker
[3]
Anti-CD22 mAb AbLJ
ADC Info ADC Name Payload Target Linker Ref
AbLJ-ConjA
AbLJ-ConjA payload
Undisclosed
AbLJ-ConjA linker
[3]
AbLJ-ConjB
AbLJ-ConjB payload
Undisclosed
AbLJ-ConjB linker
[3]
AbLJ-ConjC
AbLJ-ConjC payload
Undisclosed
AbLJ-ConjC linker
[3]
AbLJ-ConjD
AbLJ-ConjD payload
Undisclosed
AbLJ-ConjD linker
[3]
AbLJ-ConjE
AbLJ-ConjE payload
Undisclosed
AbLJ-ConjE linker
[3]
AbLJ-ConjF
AbLJ-ConjF payload
Undisclosed
AbLJ-ConjF linker
[3]
AbLJ-ConjG
AbLJ-ConjG payload
Undisclosed
AbLJ-ConjG linker
[3]
AbLJ-ConjH
AbLJ-ConjH payload
Undisclosed
AbLJ-ConjH linker
[3]
Anti-CD22 mAb HB22.7
ADC Info ADC Name Payload Target Linker Ref
HB22.7-SAP
Saporin
Microtubule (MT)
Undisclosed
[4]
Anti-CD22 mAb xCD22
ADC Info ADC Name Payload Target Linker Ref
WO2013055987A1 xCD22-103
SG2000
Human Deoxyribonucleic acid (hDNA)
WO2013055987A1_xCD22-103 linker
[5]
Anti-CD22-HC-A140C
ADC Info ADC Name Payload Target Linker Ref
Alpha-CD22-HC-A140C-10
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-peptidomimetic based linker 10
[6]
Alpha-CD22-HC-A140C-11
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-PEG2
[6]
Anti-CD22-LC-K149C
ADC Info ADC Name Payload Target Linker Ref
ACD22-LC-K149C-10
PA-seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-cBu-Cit
[7]
Alpha-CD22-LC-K149C-10
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-peptidomimetic based linker 10
[6]
Alpha-CD22-LC-K149C-11
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2
[6]
Alpha-CD22-LC-K149C-12
Seco-CBI-dimer 12
Human Deoxyribonucleic acid (hDNA)
Mc-peptidomimetic based linker 12
[6]
Anti-CD22-LC-V205C
ADC Info ADC Name Payload Target Linker Ref
Alpha-CD22-LC-V205C-10
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-peptidomimetic based linker 10
[6]
CN105828840B_ADC-101 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-101
CN105828840B_ADC-101 payload
Undisclosed
CN105828840B_ADC-101 linker
[8]
CN105828840B_ADC-104 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-104
CN105828840B_ADC-104 payload
Undisclosed
CN105828840B_ADC-104 linker
[8]
CN105828840B_ADC-108 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-108
CN105828840B_ADC-108 payload
Undisclosed
CN105828840B_ADC-108 linker
[8]
CN105828840B_ADC-110 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-110
CN105828840B_ADC-110 payload
Undisclosed
CN105828840B_ADC-110 linker
[8]
CN105828840B_ADC-111 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-111
CN105828840B_ADC-111 payload
Undisclosed
CN105828840B_ADC-111 linker
[8]
CN105828840B_ADC-115 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-115
CN105828840B_ADC-115 payload
Undisclosed
CN105828840B_ADC-115 linker
[8]
CN105828840B_ADC-116 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-116
CN105828840B_ADC-116 payload
Undisclosed
CN105828840B_ADC-116 linker
[8]
CN105828840B_ADC-120 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-120
CN105828840B_ADC-120 payload
Undisclosed
CN105828840B_ADC-120 linker
[8]
CN105828840B_ADC-122 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-122
CN105828840B_ADC-122 payload
Undisclosed
CN105828840B_ADC-122 linker
[8]
CN105828840B_ADC-124 antibody
ADC Info ADC Name Payload Target Linker Ref
CN105828840B ADC-124
CN105828840B_ADC-124 payload
Undisclosed
CN105828840B_ADC-124 linker
[8]
Epratuzumab
ADC Info ADC Name Payload Target Linker Ref
ADCT-602
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
[9]
Epratuzumab-SN38
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2A
[10]
BAY-1862864
Undisclosed
Undisclosed
Undisclosed
[11]
RNAse monoclonal antibody-LL2-I-131-conjugate
Undisclosed
Undisclosed
Undisclosed
[12]
Emab-CL2E-SN38
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2E
[13]
HLL2-PBD
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
[14]
Epratuzumab-CL2E-SN-38
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2E
[15]
Epratuzumab-SN-38
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2A
[15]
Inotuzumab
ADC Info ADC Name Payload Target Linker Ref
Inotuzumab ozogamicin
N-acetyl-gamma-calicheamicin
Human Deoxyribonucleic acid (hDNA)
AcButDMH
[16]
Inotuzumab-ADC-24-1
Inotuzumab-ADC-24-1 payload
Undisclosed
Inotuzumab-ADC-24-1 linker
[17]
Inotuzumab-ADC-24-2
Inotuzumab-ADC-24-2 payload
Undisclosed
Inotuzumab-ADC-24-2 linker
[17]
Inotuzumab-ADC-24-3
Inotuzumab-ADC-24-3 payload
Undisclosed
Inotuzumab-ADC-24-3 linker
[17]
Inotuzumab-ADC-24-4
Inotuzumab-ADC-24-4 payload
Undisclosed
Inotuzumab-ADC-24-4 linker
[17]
Inotuzumab-ADC-24-5
Inotuzumab-ADC-24-5 payload
Undisclosed
Inotuzumab-ADC-24-5 linker
[17]
Inotuzumab-ADC-24-6
Inotuzumab-ADC-24-6 payload
Undisclosed
Inotuzumab-ADC-24-6 linker
[17]
Inotuzumab-ADC-24-7
Inotuzumab-ADC-24-7 payload
Undisclosed
Inotuzumab-ADC-24-7 linker
[17]
Inotuzumab-ADC-24-8
Inotuzumab-ADC-24-8 payload
Undisclosed
Inotuzumab-ADC-24-8 linker
[17]
Inotuzumab-ADC-24-9
Inotuzumab-ADC-24-9 payload
Undisclosed
Inotuzumab-ADC-24-9 linker
[17]
Inotuzumab-ADC-24-10
Inotuzumab-ADC-24-10 payload
Undisclosed
Inotuzumab-ADC-24-10 linker
[17]
Inotuzumab-ADC-24-11
Inotuzumab-ADC-24-11 payload
Undisclosed
Inotuzumab-ADC-24-11 linker
[17]
Inotuzumab-ADC-24-12
Inotuzumab-ADC-24-12 payload
Undisclosed
Inotuzumab-ADC-24-12 linker
[17]
Inotuzumab-ADC-24-13
Inotuzumab-ADC-24-13 payload
Undisclosed
Inotuzumab-ADC-24-13 linker
[17]
Moxetumomab
ADC Info ADC Name Payload Target Linker Ref
Moxetumomab pasudotox
Pseudomonas exotoxin PE38
Eukaryotic elongation factor 2 (EEF2)
Mc-Val-Cit-PABC
[18]
Pinatuzumab
ADC Info ADC Name Payload Target Linker Ref
Anti-CD22- (LC:K149C)-SN36248
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2
[1]
Anti-CD22-NMS249
PNU-159682
DNA topoisomerase 2-alpha (TOP2A)
Mc-Val-Cit-PAB-DEA
[19]
Pinatuzumab-ADC-24-1
Pinatuzumab-ADC-24-1 payload
Undisclosed
Pinatuzumab-ADC-24-1 linker
[17]
Pinatuzumab-ADC-24-2
Pinatuzumab-ADC-24-2 payload
Undisclosed
Pinatuzumab-ADC-24-2 linker
[17]
Pinatuzumab-ADC-24-3
Pinatuzumab-ADC-24-3 payload
Undisclosed
Pinatuzumab-ADC-24-3 linker
[17]
Pinatuzumab-ADC-24-4
Pinatuzumab-ADC-24-4 payload
Undisclosed
Pinatuzumab-ADC-24-4 linker
[17]
Pinatuzumab-ADC-24-5
Pinatuzumab-ADC-24-5 payload
Undisclosed
Pinatuzumab-ADC-24-5 linker
[17]
Pinatuzumab-ADC-24-6
Pinatuzumab-ADC-24-6 payload
Undisclosed
Pinatuzumab-ADC-24-6 linker
[17]
Pinatuzumab-ADC-24-7
Pinatuzumab-ADC-24-7 payload
Undisclosed
Pinatuzumab-ADC-24-7 linker
[17]
Pinatuzumab-ADC-24-8
Pinatuzumab-ADC-24-8 payload
Undisclosed
Pinatuzumab-ADC-24-8 linker
[17]
Pinatuzumab-ADC-24-9
Pinatuzumab-ADC-24-9 payload
Undisclosed
Pinatuzumab-ADC-24-9 linker
[17]
Pinatuzumab-ADC-24-10
Pinatuzumab-ADC-24-10 payload
Undisclosed
Pinatuzumab-ADC-24-10 linker
[17]
Pinatuzumab-ADC-24-11
Pinatuzumab-ADC-24-11 payload
Undisclosed
Pinatuzumab-ADC-24-11 linker
[17]
Pinatuzumab-ADC-24-12
Pinatuzumab-ADC-24-12 payload
Undisclosed
Pinatuzumab-ADC-24-12 linker
[17]
Pinatuzumab-ADC-24-13
Pinatuzumab-ADC-24-13 payload
Undisclosed
Pinatuzumab-ADC-24-13 linker
[17]
Pinatuzumab vedotin
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
[20]
ADC Info ADC Name Payload Target Linker Ref
RFB4-SMPT-dgA
Deglycosylated ricin A-chain (dgA)
Undisclosed
Succynimidyloxycarbonyl-alpha-methyl-alpha-(2-pyridyl-dithio) toluene (SMPT)
[21]
Thio Anti-CD22 10F4v3 LC V205C
ADC Info ADC Name Payload Target Linker Ref
WO2017214024A1 ADC-101
WO2017214024A1_ADC-101 payload
Undisclosed
WO2017214024A1_ADC-101 linker
[22]
Thio hu Anti-CD22 10F43 HC L177C
ADC Info ADC Name Payload Target Linker Ref
WO2017059289A1 ADC-116
WO2017059289A1_ADC-116 payload
Undisclosed
WO2017059289A1_ADC-116 linker
[23]
Thio hu Anti-CD22 10F4v3
ADC Info ADC Name Payload Target Linker Ref
WO2017059289A1 ADC-202
WO2017059289A1_ADC-202 payload
Undisclosed
WO2017059289A1_ADC-202 linker
[23]
Thio hu Anti-CD22 10F4v3 HC A118C
ADC Info ADC Name Payload Target Linker Ref
WO2014159981A2 ADC-115
WO2014159981A2_ADC-115 payload
Undisclosed
WO2014159981A2_ADC-115 linker
[24]
WO2014159981A2 ADC-125
WO2014159981A2_ADC-125 payload
Undisclosed
WO2014159981A2_ADC-125 linker
[24]
WO2014159981A2 ADC-212
WO2014159981A2_ADC-212 payload
Undisclosed
WO2014159981A2_ADC-212 linker
[24]
WO2014159981A2 ADC-135
WO2014159981A2_ADC-135 payload
Undisclosed
WO2014159981A2_ADC-135 linker
[24]
WO2014159981A2 ADC-CD22-44
WO2014159981A2_ADC-CD22-44 payload
Undisclosed
WO2014159981A2_ADC-CD22-44 linker
[24]
WO2014159981A2 ADC-CD22-48
WO2014159981A2_ADC-CD22-48 payload
Undisclosed
WO2014159981A2_ADC-CD22-48 linker
[24]
WO2014159981A2 ADC-CD22-22
WO2014159981A2_ADC-CD22-22 payload
Undisclosed
WO2014159981A2_ADC-CD22-22 linker
[24]
WO2014159981A2 ADC-CD22-41
WO2014159981A2_ADC-CD22-41 payload
Undisclosed
WO2014159981A2_ADC-CD22-41 linker
[24]
Thio hu Anti-CD22 10F4v3 HC A140C
ADC Info ADC Name Payload Target Linker Ref
WO2017214024A1 ADC-105
WO2017214024A1_ADC-105 payload
Undisclosed
WO2017214024A1_ADC-105 linker
[22]
Thio hu Anti-CD22 10F4v3 HC Y376C
ADC Info ADC Name Payload Target Linker Ref
WO2017059289A1 ADC-118
WO2017059289A1_ADC-118 payload
Undisclosed
WO2017059289A1_ADC-118 linker
[23]
Thio hu Anti-CD22 10F4v3 LC K149C
ADC Info ADC Name Payload Target Linker Ref
WO2017059289A1 ADC-103
WO2017059289A1_ADC-103 payload
Undisclosed
WO2017059289A1_ADC-103 linker
[23]
WO2017059289A1 ADC-105
WO2017059289A1_ADC-105 payload
Undisclosed
WO2017059289A1_ADC-105 linker
[23]
WO2017059289A1 ADC-107
WO2017059289A1_ADC-107 payload
Undisclosed
WO2017059289A1_ADC-107 linker
[23]
WO2017059289A1 ADC-110
WO2017059289A1_ADC-110 payload
Undisclosed
WO2017059289A1_ADC-110 linker
[23]
WO2017059289A1 ADC-204
WO2017059289A1_ADC-204 payload
Undisclosed
WO2017059289A1_ADC-204 linker
[23]
WO2017059289A1 ADC-206
WO2017059289A1_ADC-206 payload
Undisclosed
WO2017059289A1_ADC-206 linker
[23]
WO2017059289A1 ADC-207
WO2017059289A1_ADC-207 payload
Undisclosed
WO2017059289A1_ADC-207 linker
[23]
WO2017214024A1 ADC-104
WO2017214024A1_ADC-104 payload
Undisclosed
WO2017214024A1_ADC-104 linker
[22]
WO2017214024A1 ADC-108
WO2017214024A1_ADC-108 payload
Undisclosed
WO2017214024A1_ADC-108 linker
[22]
WO2017214024A1 ADC-110
WO2017214024A1_ADC-110 payload
Undisclosed
WO2017214024A1_ADC-110 linker
[22]
Thio hu Anti-CD22 10F4v3 LC K149C HC L177C
ADC Info ADC Name Payload Target Linker Ref
WO2017059289A1 ADC-111
WO2017059289A1_ADC-111 payload
Undisclosed
WO2017059289A1_ADC-111 linker
[23]
WO2017059289A1 ADC-112
WO2017059289A1_ADC-112 payload
Undisclosed
WO2017059289A1_ADC-112 linker
[23]
Undisclosed
ADC Info ADC Name Payload Target Linker Ref
TAC-001
Differentiated TLR-9 agonist (T-CpG)
Toll-like receptor 9 (TLR9)
Undisclosed
[25]
TRPH-222
Maytansinoid
Microtubule (MT)
Undisclosed
[26]
Anti-CD22 antibody drug-conjugate (Medarex/BMS)
Undisclosed
Undisclosed
Undisclosed
[27]
Anti-CD22 antibody-drug conjugate (Ambrx)
Undisclosed
Undisclosed
Undisclosed
[28]
Tissue/Disease specific Abundances of This Antigen
Tissue specific Abundances of This Antigen
ICD Disease Classification 01
Click to Show/Hide the 1 Disease of This Class
Bacterial infection [ICD-11: 1A00-1C4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gingival
The Specific Disease Bacterial infection of gingival
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 7.63E-15; Fold-change: 0.324121092; Z-score: 1.331251827
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 02
Click to Show/Hide the 22 Disease of This Class
Brain cancer [ICD-11: 2A00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Brainstem
The Specific Disease Glioma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.014132974; Fold-change: -1.578440596; Z-score: -9.55296882
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue White matter
The Specific Disease Glioma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.001195006; Fold-change: -1.024981823; Z-score: -1.751946496
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Brainstem
The Specific Disease Neuroectodermal tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.82E-09; Fold-change: -1.576291081; Z-score: -6.723357581
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Nervous
The Specific Disease Brain cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.30E-103; Fold-change: -1.281366451; Z-score: -1.585343532
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic myeloid leukemia [ICD-11: 2A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Polycythemia vera
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 9.24E-09; Fold-change: -0.3893891; Z-score: -1.680620845
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Whole blood
The Specific Disease Myelofibrosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.97E-05; Fold-change: -0.489015375; Z-score: -1.722154604
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
MyeloDysplastic syndromes [ICD-11: 2A37]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Myelodysplastic syndromes
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 2.26E-09; Fold-change: -0.560977873; Z-score: -1.474118472
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.101552992; Fold-change: -1.055350327; Z-score: -1.435793957
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lymphoma [ICD-11: 2A90- 2A85]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Tonsil
The Specific Disease Lymphoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.598292491; Fold-change: 0.137048949; Z-score: 0.286507434
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Gastric cancer [ICD-11: 2B72]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gastric
The Specific Disease Gastric cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.167478653; Fold-change: -0.617420844; Z-score: -1.829445511
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.04050186; Fold-change: -0.328644753; Z-score: -0.476074428
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Colon cancer [ICD-11: 2B90]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Colon
The Specific Disease Colon cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.80E-18; Fold-change: -0.346869264; Z-score: -0.665076181
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 4.57E-15; Fold-change: -0.289591363; Z-score: -0.665445097
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pancreatic cancer [ICD-11: 2C10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pancreas
The Specific Disease Pancreatic cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.075084502; Fold-change: -0.240903304; Z-score: -0.266041872
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 6.48E-06; Fold-change: -0.438459529; Z-score: -0.555935616
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Liver cancer [ICD-11: 2C12]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Liver cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000458833; Fold-change: -0.128039161; Z-score: -0.656402195
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 3.83E-11; Fold-change: -0.135463058; Z-score: -0.619536876
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.317188099; Fold-change: -0.234331697; Z-score: -0.656689652
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lung cancer [ICD-11: 2C25]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Lung cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.09E-17; Fold-change: -0.282766326; Z-score: -0.762158311
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 4.28E-15; Fold-change: -0.305994004; Z-score: -0.884042103
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Melanoma [ICD-11: 2C30]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Melanoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 5.68E-05; Fold-change: 0.382077492; Z-score: 0.968848072
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sarcoma [ICD-11: 2C35]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Sarcoma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 7.27E-16; Fold-change: -0.236036021; Z-score: -0.723641984
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.023017722; Fold-change: -0.441776735; Z-score: -3.001987792
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Breast cancer [ICD-11: 2C60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Breast
The Specific Disease Breast cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.17E-10; Fold-change: 0.134511935; Z-score: 0.41268807
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.133675931; Fold-change: 0.076366668; Z-score: 0.19777896
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ovarian cancer [ICD-11: 2C73]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Ovarian
The Specific Disease Ovarian cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.61E-05; Fold-change: -2.583685935; Z-score: -3.529089248
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.491482319; Fold-change: -0.116233775; Z-score: -0.247384118
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Cervical cancer [ICD-11: 2C77]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Cervical
The Specific Disease Cervical cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.542631949; Fold-change: 0.073738656; Z-score: 0.280461132
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Uterine cancer [ICD-11: 2C78]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Endometrium
The Specific Disease Uterine cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.35E-09; Fold-change: 0.208751578; Z-score: 0.741593929
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.063864511; Fold-change: -0.16583691; Z-score: -0.975646774
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Prostate cancer [ICD-11: 2C82]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Prostate
The Specific Disease Prostate cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.924623156; Fold-change: 0.142971001; Z-score: 0.190276696
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Bladder cancer [ICD-11: 2C94]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bladder
The Specific Disease Bladder cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.55748764; Fold-change: -0.050021237; Z-score: -0.187113607
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Retina cancer [ICD-11: 2D02]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Uvea
The Specific Disease Retinoblastoma tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.719384018; Fold-change: -9.59E-05; Z-score: -0.001035094
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Thyroid cancer [ICD-11: 2D10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Thyroid
The Specific Disease Thyroid cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.099621021; Fold-change: 0.125571268; Z-score: 0.126003528
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.000217147; Fold-change: 0.522049054; Z-score: 0.637037059
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Adrenal cancer [ICD-11: 2D11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Adrenal cortex
The Specific Disease Adrenocortical carcinoma
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.390962545; Fold-change: -0.291079496; Z-score: -0.662902372
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Head and neck cancer [ICD-11: 2D42]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Head and neck
The Specific Disease Head and neck cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.117560111; Fold-change: 0.057835292; Z-score: 0.064501781
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pituitary cancer [ICD-11: 2F37]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pituitary
The Specific Disease Pituitary gonadotrope tumor
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.08713732; Fold-change: 0.174074757; Z-score: 1.04846669
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Pituitary
The Specific Disease Pituitary cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000382027; Fold-change: 0.253658449; Z-score: 1.589521123
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 03
Click to Show/Hide the 1 Disease of This Class
Thrombocytopenia [ICD-11: 3B64]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Thrombocytopenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.69048606; Fold-change: 0.675894133; Z-score: 0.44493011
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 04
Click to Show/Hide the 2 Disease of This Class
Lupus erythematosus [ICD-11: 4A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Lupus erythematosus
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.152285462; Fold-change: -0.092424955; Z-score: -0.074202707
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Autoimmune disease [ICD-11: 4A4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral monocyte
The Specific Disease Autoimmune uveitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.519425825; Fold-change: 0.115577372; Z-score: 0.86827976
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 05
Click to Show/Hide the 1 Disease of This Class
Hyperlipoproteinaemia [ICD-11: 5C80]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Familial hypercholesterolemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 3.02E-09; Fold-change: -0.620049282; Z-score: -1.297382947
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 06
Click to Show/Hide the 1 Disease of This Class
Schizophrenia [ICD-11: 6A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Superior temporal cortex
The Specific Disease Schizophrenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.557805406; Fold-change: -0.016194209; Z-score: -0.042198067
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 08
Click to Show/Hide the 3 Disease of This Class
Multiple sclerosis [ICD-11: 8A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Spinal cord
The Specific Disease Multiple sclerosis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.096368559; Fold-change: -0.148873039; Z-score: -0.744976572
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Plasmacytoid dendritic cells
The Specific Disease Multiple sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.454123466; Fold-change: -0.187611254; Z-score: -0.429690137
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Epilepsy [ICD-11: 8A60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peritumoral cortex
The Specific Disease Epilepsy
The Expression Level of Disease Section Compare with the Other Disease Section p-value: 0.351993043; Fold-change: 0.286822239; Z-score: 2.322835104
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Cerebral ischaemic stroke [ICD-11: 8B11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Cardioembolic Stroke
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 6.15E-10; Fold-change: -0.966139087; Z-score: -1.917007686
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Peripheral blood
The Specific Disease Ischemic stroke
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.892896922; Fold-change: -0.103684962; Z-score: -0.149475872
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 1
Click to Show/Hide the 6 Disease of This Class
HIV [ICD-11: 1C60-1C62]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue White matter
The Specific Disease HIV
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.389617545; Fold-change: 0.355426889; Z-score: 0.4081668
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Influenza [ICD-11: 1E30]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Influenza
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.035624774; Fold-change: 0.261540542; Z-score: 2.006498399
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic hepatitis C [ICD-11: 1E51.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Chronic hepatitis C
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.537478523; Fold-change: 0.013364507; Z-score: 0.054593223
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sepsis [ICD-11: 1G40-1G41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Sepsis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.98E-07; Fold-change: -0.85483905; Z-score: -1.162066597
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Septic shock [ICD-11: 1G41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Septic shock
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.75E-31; Fold-change: -0.745273964; Z-score: -1.367466117
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pediatric respiratory syncytial virus infection [ICD-11: CA40.11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Pediatric respiratory syncytial virus infection
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.004382864; Fold-change: -0.512112546; Z-score: -0.909155196
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 11
Click to Show/Hide the 6 Disease of This Class
Essential hypertension [ICD-11: BA00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Essential hypertension
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.30324301; Fold-change: -0.11201689; Z-score: -0.502772557
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myocardial infarction [ICD-11: BA41]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Myocardial infarction
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.195344505; Fold-change: -0.185263493; Z-score: -0.254222575
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Coronary artery disease [ICD-11: BA8Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Coronary artery disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.151022523; Fold-change: -0.258463149; Z-score: -0.666672909
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Aortic stenosis [ICD-11: BB70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Calcified aortic valve
The Specific Disease Aortic stenosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.963231054; Fold-change: -0.059155648; Z-score: -0.162002621
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arteriosclerosis [ICD-11: BD40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arteriosclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.112244314; Fold-change: 0.165733669; Z-score: 0.599715918
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Aneurysm [ICD-11: BD50]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Intracranial artery
The Specific Disease Aneurysm
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.171014457; Fold-change: 0.089143313; Z-score: 0.309628531
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 12
Click to Show/Hide the 8 Disease of This Class
Immunodeficiency [ICD-11: 4A00-4A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Immunodeficiency
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.248274413; Fold-change: 0.074791057; Z-score: 0.570220459
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Apnea [ICD-11: 7A40]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Hyperplastic tonsil
The Specific Disease Apnea
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.224662378; Fold-change: 0.686475785; Z-score: 4.858888285
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Olive pollen allergy [ICD-11: CA08.00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Olive pollen allergy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.021088938; Fold-change: 0.288338163; Z-score: 2.098009064
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic rhinosinusitis [ICD-11: CA0A]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Sinus mucosa
The Specific Disease Chronic rhinosinusitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.773004585; Fold-change: 0.030295802; Z-score: 0.291316683
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Chronic obstructive pulmonary disease [ICD-11: CA22]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Chronic obstructive pulmonary disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.234702263; Fold-change: -0.020272862; Z-score: -0.07418088
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Small airway epithelium
The Specific Disease Chronic obstructive pulmonary disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000197778; Fold-change: 0.214634078; Z-score: 0.806897034
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Asthma [ICD-11: CA23]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Nasal and bronchial airway
The Specific Disease Asthma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.558373568; Fold-change: -0.020194019; Z-score: -0.064371631
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Human rhinovirus infection [ICD-11: CA42]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Nasal Epithelium
The Specific Disease Human rhinovirus infection
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.599293673; Fold-change: -0.052142261; Z-score: -0.487903543
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Lung
The Specific Disease Idiopathic pulmonary fibrosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 5.44E-05; Fold-change: 0.432646922; Z-score: 5.218334892
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 13
Click to Show/Hide the 5 Disease of This Class
Periodontal disease [ICD-11: DA0C]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gingival
The Specific Disease Periodontal disease
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 3.74E-12; Fold-change: 0.295838282; Z-score: 1.118095993
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Eosinophilic gastritis [ICD-11: DA42.2]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Gastric antrum
The Specific Disease Eosinophilic gastritis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.044731656; Fold-change: 0.114279743; Z-score: 0.932177197
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Liver failure [ICD-11: DB99.7-DB99.8]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Liver failure
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.40E-05; Fold-change: 0.540398212; Z-score: 3.343738473
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ulcerative colitis [ICD-11: DD71]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Colon mucosal
The Specific Disease Ulcerative colitis
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.001448742; Fold-change: 0.359238384; Z-score: 1.233335108
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Irritable bowel syndrome [ICD-11: DD91.0]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Rectal colon
The Specific Disease Irritable bowel syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.200205992; Fold-change: 0.04994636; Z-score: 0.077442051
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 14
Click to Show/Hide the 5 Disease of This Class
Atopic dermatitis [ICD-11: EA80]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Atopic dermatitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.679542645; Fold-change: -0.017122442; Z-score: -0.131474548
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Psoriasis [ICD-11: EA90]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Psoriasis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.013154763; Fold-change: -0.210298101; Z-score: -0.646304127
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 2.02E-21; Fold-change: 0.271282447; Z-score: 1.454467825
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Vitiligo [ICD-11: ED63.0]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Vitiligo
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.254434626; Fold-change: -0.086635319; Z-score: -0.8140312
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Alopecia [ICD-11: ED70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin from scalp
The Specific Disease Alopecia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.010365552; Fold-change: 0.074227608; Z-score: 0.261156528
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sensitive skin [ICD-11: EK0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Sensitive skin
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.21059204; Fold-change: -0.083078099; Z-score: -0.736637111
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 15
Click to Show/Hide the 6 Disease of This Class
Osteoarthritis [ICD-11: FA00-FA0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Synovial
The Specific Disease Osteoarthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.159872158; Fold-change: -0.276780885; Z-score: -0.692690657
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arthropathy [ICD-11: FA00-FA5Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arthropathy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.370274148; Fold-change: -0.272280385; Z-score: -0.684289404
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Arthritis [ICD-11: FA20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Arthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 9.61E-07; Fold-change: -0.740385402; Z-score: -1.085507609
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Rheumatoid arthritis [ICD-11: FA20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Synovial
The Specific Disease Rheumatoid arthritis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.007284588; Fold-change: -0.575905418; Z-score: -1.736650742
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ankylosing spondylitis [ICD-11: FA92.0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Pheripheral blood
The Specific Disease Ankylosing spondylitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.046600225; Fold-change: 0.196516089; Z-score: 0.439312397
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Osteoporosis [ICD-11: FB83]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Osteoporosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.544670802; Fold-change: 0.027909739; Z-score: 0.517252474
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 16
Click to Show/Hide the 2 Disease of This Class
Endometriosis [ICD-11: GA10]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Endometrium
The Specific Disease Endometriosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.010461027; Fold-change: 0.149512828; Z-score: 0.497614312
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Interstitial cystitis [ICD-11: GC00.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bladder
The Specific Disease Interstitial cystitis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000998895; Fold-change: 0.700684881; Z-score: 4.148670453
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 19
Click to Show/Hide the 1 Disease of This Class
Preterm birth [ICD-11: KA21.4Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Myometrium
The Specific Disease Preterm birth
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.200999031; Fold-change: 0.197197528; Z-score: 1.203362135
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 2
Click to Show/Hide the 8 Disease of This Class
Acute myelocytic leukemia [ICD-11: 2A60]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Acute myelocytic leukemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 1.89E-11; Fold-change: -0.210620126; Z-score: -0.576256135
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myeloma [ICD-11: 2A83]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Myeloma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.995792669; Fold-change: 0.054991716; Z-score: 0.271336217
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Peripheral blood
The Specific Disease Myeloma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.220643496; Fold-change: -0.000869259; Z-score: -0.007565259
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Oral cancer [ICD-11: 2B6E]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Oral
The Specific Disease Oral cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.008894136; Fold-change: -0.305366511; Z-score: -0.41826501
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.932691817; Fold-change: 0.047405525; Z-score: 0.139682262
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Esophagal cancer [ICD-11: 2B70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Esophagus
The Specific Disease Esophagal cancer
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.011681289; Fold-change: -0.143361739; Z-score: -2.05199215
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Rectal cancer [ICD-11: 2B92]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Rectal colon
The Specific Disease Rectal cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.115982058; Fold-change: -0.192461338; Z-score: -0.605027974
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.009833871; Fold-change: -0.362829314; Z-score: -1.275355221
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Skin cancer [ICD-11: 2C30-2C3Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Skin cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 4.16E-11; Fold-change: 0.05329432; Z-score: 0.140194058
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 2.37E-57; Fold-change: 0.657102779; Z-score: 2.865769141
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Renal cancer [ICD-11: 2C90-2C91]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Kidney
The Specific Disease Renal cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.002696093; Fold-change: -0.385599763; Z-score: -1.813905263
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 1.82E-07; Fold-change: -0.247443928; Z-score: -1.08744492
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Ureter cancer [ICD-11: 2C92]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Urothelium
The Specific Disease Ureter cancer
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.715898176; Fold-change: 0.018574313; Z-score: 0.0717893
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 20
Click to Show/Hide the 2 Disease of This Class
Simpson golabi behmel syndrome [ICD-11: LD2C]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Adipose
The Specific Disease Simpson golabi behmel syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.30157735; Fold-change: 0.080343795; Z-score: 0.870109979
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Tuberous sclerosis complex [ICD-11: LD2D.2]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Perituberal
The Specific Disease Tuberous sclerosis complex
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.589735221; Fold-change: -0.130642366; Z-score: -0.461822372
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 3
Click to Show/Hide the 3 Disease of This Class
Anemia [ICD-11: 3A00-3A9Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Bone marrow
The Specific Disease Anemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.011678271; Fold-change: -1.038480842; Z-score: -1.409852029
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sickle cell disease [ICD-11: 3A51.0-3A51.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Sickle cell disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.954003403; Fold-change: -0.076170795; Z-score: -0.358847672
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Thrombocythemia [ICD-11: 3B63]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Thrombocythemia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.796288098; Fold-change: 0.043568598; Z-score: 0.153472357
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 4
Click to Show/Hide the 4 Disease of This Class
Scleroderma [ICD-11: 4A42.Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Scleroderma
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000220918; Fold-change: -1.53414554; Z-score: -2.442130261
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Sjogren syndrome [ICD-11: 4A43]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Salivary gland
The Specific Disease Sjogren syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.257128681; Fold-change: 0.530560403; Z-score: 2.037323377
The Expression Level of Disease Section Compare with the Adjacent Tissue p-value: 0.087649725; Fold-change: -0.09372665; Z-score: -0.547240468
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Behcet disease [ICD-11: 4A62]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Peripheral blood
The Specific Disease Behcet disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.187538405; Fold-change: -0.348626515; Z-score: -0.593534243
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Autosomal dominant monocytopenia [ICD-11: 4B04]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Autosomal dominant monocytopenia
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.013870954; Fold-change: -0.232051565; Z-score: -1.734945308
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 5
Click to Show/Hide the 5 Disease of This Class
Type 2 diabetes [ICD-11: 5A11]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Liver
The Specific Disease Type 2 diabetes
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.05682211; Fold-change: -0.289123252; Z-score: -1.427031917
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Polycystic ovary syndrome [ICD-11: 5A80.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Vastus lateralis muscle
The Specific Disease Polycystic ovary syndrome
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.217640656; Fold-change: -0.061729435; Z-score: -0.424241809
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Obesity [ICD-11: 5B81]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Subcutaneous Adipose
The Specific Disease Obesity
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.937998447; Fold-change: -0.029298665; Z-score: -0.183315985
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Pompe disease [ICD-11: 5C51.3]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Biceps muscle
The Specific Disease Pompe disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.617677672; Fold-change: -0.00148253; Z-score: -0.010824235
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Batten disease [ICD-11: 5C56.1]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Batten disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.972696587; Fold-change: 0.326518524; Z-score: 0.572466414
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 6
Click to Show/Hide the 2 Disease of This Class
Autism [ICD-11: 6A02]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Autism
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.057236963; Fold-change: -0.149085126; Z-score: -0.33607489
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Anxiety disorder [ICD-11: 6B00-6B0Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Anxiety disorder
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.047166228; Fold-change: -0.202223866; Z-score: -0.389533126
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
ICD Disease Classification 8
Click to Show/Hide the 7 Disease of This Class
Parkinson disease [ICD-11: 8A00]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Substantia nigra
The Specific Disease Parkinson disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.068536064; Fold-change: 0.204942422; Z-score: 0.439248948
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Huntington disease [ICD-11: 8A01]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Huntington disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.960746065; Fold-change: -0.029189131; Z-score: -0.0628178
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Alzheimer disease [ICD-11: 8A20]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Entorhinal cortex
The Specific Disease Alzheimer disease
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.00011918; Fold-change: 0.382905267; Z-score: 0.517775407
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Seizure [ICD-11: 8A60-8A6Z]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Whole blood
The Specific Disease Seizure
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.798187648; Fold-change: 0.111755665; Z-score: 0.128821752
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Lateral sclerosis [ICD-11: 8B60.4]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Skin
The Specific Disease Lateral sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.281952262; Fold-change: -0.033198721; Z-score: -0.855679488
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
The Studied Tissue Cervical spinal cord
The Specific Disease Lateral sclerosis
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.512320634; Fold-change: -0.052227862; Z-score: -0.328999621
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Muscular atrophy [ICD-11: 8C70]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Muscular atrophy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.000591328; Fold-change: -0.32996056; Z-score: -1.371461848
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
Myopathy [ICD-11: 8C70.6]
Click to Show/Hide
Differential expression pattern of antigen in diseases
The Studied Tissue Muscle
The Specific Disease Myopathy
The Expression Level of Disease Section Compare with the Healthy Individual Tissue p-value: 0.012860359; Fold-change: -0.202296893; Z-score: -2.097795202
Disease-specific Antigen Abundances Click to View the Clearer Original Diagram
References
Ref 1 An Anti-CD22-seco-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models. Mol Cancer Ther. 2021 Feb;20(2):340-346.
Ref 2 Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates. Chem Sci. 2017 Jan 1;8(1):366-370. doi: 10.1039/c6sc01831a. Epub 2016 Aug 22.
Ref 3 Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using.
Ref 4 The HB22.7 Anti-CD22 Monoclonal Antibody Is an Effective Platform for CD22-Targeted Antibody Drug Conjugates for Treatment of Lymphoma and Acute Lymphoblastic Leukemia. Blood. 2012 ;120(21):-. doi: 10.1182/blood.V120.21.1653.1653.
Ref 5 Pyrrolobenzodiazepines and conjugates thereof; 2013-04-18.
Ref 6 Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo. Bioconjug Chem. 2019 May 15;30(5):1356-1370. doi: 10.1021/acs.bioconjchem.9b00133. Epub 2019 Apr 22.
Ref 7 Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo. Bioconjug Chem. 2019 May 15;30(5):1356-1370. doi: 10.1021/acs.bioconjchem.9b00133. Epub 2019 Apr 22.
Ref 8 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment.
Ref 9 A Phase 1 Trial of Adct-602, a CD22 Targeting Antibody Drug Conjugate Bound to PBD Toxin in Adult Patients with Relapsed or Refractory CD22+B-Cell Acute Lymphoblastic Leukemia. Blood. 2021 ;138():-. doi: 10.1182/blood-2021-153141.
Ref 10 ADC review: basic information about Epratuzumab-SN-38.
Ref 11 227Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study. Cancer Biother Radiopharm. 2021 Oct;36(8):672-681. doi: 10.1089/cbr.2020.4653.
Ref 12 Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. Blood. 2001 Jan 15;97(2):528-35. doi: 10.1182/blood.v97.2.528.
Ref 13 Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies. Mol Cancer Ther. 2012 Jan;11(1):224-34.
Ref 14 Preclinical activity of hLL2-PBD, a novel anti-CD22 antibody-pyrrolobenzodiazepine (PBD) conjugate in models of non-Hodgkin lymphoma. Cancer Res (2015) 75 (15_Supplement): 637.
Ref 15 Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies. Mol Cancer Ther. 2012 Jan;11(1):224-34. doi: 10.1158/1535-7163.MCT-11-0632. Epub 2011 Oct 28.
Ref 16 Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia. N Engl J Med. 2016 Aug 25;375(8):740-53. doi: 10.1056/NEJMoa1509277. Epub 2016 Jun 12.
Ref 17 Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof; 2020-04-02.
Ref 18 Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial. J Hematol Oncol. 2021 Feb 24;14(1):35.
Ref 19 A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs. Clin Cancer Res. 2015 Jul 15;21(14):3298-306. doi: 10.1158/1078-0432.CCR-14-2035. Epub 2015 Apr 3.
Ref 20 Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS). Lancet Haematol. 2019 May;6(5):e254-e265.
Ref 21 Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study. Blood. 1995 Jun 15;85(12):3457-65.
Ref 22 Silvestrol antibody-drug conjugates and methods of use; 2017-12-14.
Ref 23 Pyrrolobenzodiazepine antibody drug conjugates and methods of use; 2017-04-06.
Ref 24 Pyrrolobenzodiazepines and conjugates thereof; 2015-04-09.
Ref 25 TAC-001, a toll-like receptor 9 (TLR9) agonist antibody conjugate targeting B cells, promotes anti-tumor immunity and favorable safety profile following systemic administration in preclinical models. Cancer Res (2021) 81 (13_Supplement): 1721.
Ref 26 A Phase I Pharmacokinetic (PK) and Safety Study of Trph-222 in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL): Dose-Escalation Results. Blood 2020 Nov 5; 136(1): 41-42.
Ref 27 Introduction to basic information on anti-CD22 antibody drug-conjugates(Medarex/BMS).
Ref 28 Introduction to basic information on anti-CD22 antibody-drug conjugate(Ambrx).

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.